CARL Carlsmed Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CARL

Price (delayed)

$14.76

Market cap

$402.99M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.08

Enterprise value

$378.56M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 22
Highlights
The EPS has soared by 82% year-on-year and by 50% since the previous quarter
Carlsmed's gross profit has soared by 71% YoY and by 13% from the previous quarter
The quick ratio has soared by 82% YoY but it fell by 26% QoQ
Carlsmed's net income has decreased by 45% YoY and by 11% QoQ
The debt is up by 27% since the previous quarter and by 24% year-on-year
Sector: Healthcare
Industry: Health Information Services
Website: https://carlsmed.com
Peers: TDOC VEEV OMCL HSTM

Key stats

What are the main financial stats of CARL

CARL stock price

How has the Carlsmed stock price performed over time
Intraday
-4.28%
1 week
-3.59%
1 month
-8.04%
1 year
2.29%
YTD
19.51%
QTD
42.2%

Financial performance

How have Carlsmed's revenue and profit performed over time
Revenue
$63.3M
Gross profit
$48.5M
Operating income
-$38.67M
Net income
-$36.35M
Gross margin
76.6%
Net margin
-57.4%
Carlsmed's gross profit has soared by 71% YoY and by 13% from the previous quarter
The revenue has soared by 65% YoY and by 12% from the previous quarter
Carlsmed's operating income has plunged by 57% YoY and by 13% from the previous quarter
Carlsmed's net income has decreased by 45% YoY and by 11% QoQ

Price vs fundamentals

How does CARL's price correlate with its fundamentals

Growth

What is Carlsmed's growth rate over time

Valuation

What is Carlsmed stock price valuation
P/E
N/A
P/B
4.76
P/S
6.34
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.98
The EPS has soared by 82% year-on-year and by 50% since the previous quarter
CARL's P/B is 56% higher than its last 4 quarters average of 3.2
The equity has declined by 9% since the previous quarter
The revenue has soared by 65% YoY and by 12% from the previous quarter
CARL's P/S is 44% above its last 4 quarters average of 4.6

Efficiency

How efficient is Carlsmed business performance
The ROA has increased by 41% YoY and by 2.7% QoQ
Carlsmed's ROE has increased by 37% from the previous quarter
CARL's ROIC is up by 20% year-on-year and by 17% since the previous quarter
The ROS is up by 10% year-on-year

Dividends

What is CARL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CARL.

Financial health

How did Carlsmed financials performed over time
Carlsmed's total assets has soared by 122% YoY
The quick ratio has soared by 82% YoY but it fell by 26% QoQ
The debt is 74% smaller than the equity
The company's debt to equity rose by 37% QoQ
The debt is up by 27% since the previous quarter and by 24% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.